Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-11-07
1993-04-27
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548429, C07D48704, A61K 31405
Patent
active
052062600
ABSTRACT:
Mammalian metabilites of the known acetylchloinesterase inhibitor trimethyl-1,3a,8-hexahydro-1,2,3,3a,8,8a-pyrrol[2,3-b]indole-5(3aS,8aR) heptylcarbamate are themselves cholinesterase inhibitors useful in the treatment of various memory dysfunctions characterized by a cholinergic deficit such as Alzheimer's disease and are also useful as analgesic agents in the alleviation of pain.
REFERENCES:
patent: 4765985 (1988-08-01), Leeson
patent: 4791107 (1988-12-01), Hamer et al.
patent: 4831155 (1989-05-01), Brufani et al.
patent: 4900748 (1990-02-01), Brossi et al.
patent: 4978673 (1990-12-01), Meroni et al.
Drugs of the Future, 1991 16(1), pp. 33-36.
Stern et al., Ann. Neurol. 22: 306-310 (1987).
Unni, et al. (I), Eur. J. Clin. Pharmacol, 41: 83-84 )1991).
Somani, Biopharm. Drug Dispo., 10, 187-203 (1989).
Giacobini, et al. Neuropharm., 26, 831-836 (1987).
Somani, et al., Drug Metab. Dispo., 15, 627-633 (1987).
Unni, et al., (II), Drug Metab. Dispo., 14, 183-189 (1986).
Isaksson et al., J. Chromatog., 419, 165-175 (1987).
Hichens Martin
Kari Hanumath G. P.
Vyas Kamlesh P.
Gabilan Mary Susan H.
Lee Mary C.
Merck & Co. , Inc.
LandOfFree
Hexahydropyrrolo[2,3-b]indole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexahydropyrrolo[2,3-b]indole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexahydropyrrolo[2,3-b]indole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2327414